Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 361-372 of 1,136
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In Canada
Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT01714713

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, Canada, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT05113771

Liafensine for Depression

This study is completed in the United States and in Canada. It is testing liafensine for Depression.

In Canada
DepressionDrugFrom 18 Years to 70 Years
Countries
United States, Canada
Sponsor
Denovo Biopharma LLC
Condition
Depression
Behavioral study icon
CompletedNCT05310981

A Cannabis E-intervention for Young Cannabis Users With Early Psychosis (iCC)

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In Canada
Addiction, SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Addiction, Schizophrenia
Behavioral study icon
CompletedNCT04968275

A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.

Remote / online
SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Condition
Schizophrenia
Drug study icon
TerminatedNCT05169710

Investigational Drug for depression

This study was terminated in the United States, in Canada, in Bulgaria, .... It is testing investigational Drug for depression.

Remote / online
Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.